Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Marina Izak"'
Autor:
Dani Cohen, Marina Izak, Evgeniy Stoyanov, Michal Mandelboim, Saritte Perlman, Yonatan Amir, Sophy Goren, Anya Bialik, Limor Kliker, Nofar Atari, Ruti Yshai, Yona Zaide, Hadar Marcus, Noa Madar-Balakirski, Tomer Israely, Nir Paran, Oren Zimhony, Eilat Shinar, Yasmin Maor, Khitam Muhsen
Publikováno v:
International Journal of Infectious Diseases, Vol 132, Iss , Pp 72-79 (2023)
Objectives: The predictors of SARS-CoV-2 reinfection are unclear. We examined predictors of reinfection with pre-Omicron and Omicron variants among COVID-19-recovered individuals. Methods: Randomly selected COVID-19-recovered patients (N = 1004) who
Externí odkaz:
https://doaj.org/article/5f77e8f9a681427cbd1de9b7349733b8
Autor:
Naomi Rahimi-Levene, Jonathan Shapira, Irma Tzur, Eli Shiloah, Victoria Peer, Ella Levin, Marina Izak, Eilat Shinar, Tomer Ziv-Baran, Miriam Weinberger, Oren Zimhony, Jacob Chen, Yasmin Maor
Publikováno v:
PLoS ONE, Vol 17, Iss 7 (2022)
Several options to treat hospitalized severe COVID-19 patients have been suggested. The study aimed to describe survival in patients treated with convalescent COVID plasma (CCP) and to identify in-hospital mortality predictors. This prospective cohor
Externí odkaz:
https://doaj.org/article/bead6392495c4853ba6f71113b20536d
Autor:
Yasmin Maor, Daniel Cohen, Nir Paran, Tomer Israely, Vered Ezra, Ofra Axelrod, Eilat Shinar, Marina Izak, Galia Rahav, Naomi Rahimi-Levene, Baruch M Bazofin, Ram Gelman, Dror Dicker, Tal Brosh-Nissimov, Orli Megged, David Dahan, Avi Benov, Alona Paz, Kaykov Edward, Amit Moran, Ori Rogowski, Patrick Sorkine, Ami Mayo, Oren Zimhony, Jacob Chen
Publikováno v:
EClinicalMedicine, Vol 26, Iss , Pp 100525- (2020)
Background: We assessed outcome of patients with moderate and severe COVID-19 following treatment with convalescent plasma (CP) and the association with IgG levels in transfused CP. Methods: A prospective cohort study. Primary outcome was improvement
Externí odkaz:
https://doaj.org/article/eecd60517c3c4a7d9b10d6da187b73e7
Autor:
Yfat Yahalom-Ronen, Noam Erez, Morly Fisher, Hadas Tamir, Boaz Politi, Hagit Achdout, Sharon Melamed, Itai Glinert, Shay Weiss, Inbar Cohen-Gihon, Ofir Israeli, Marina Izak, Michal Mandelboim, Yoseph Caraco, Noa Madar-Balakirski, Adva Mechaly, Eilat Shinar, Ran Zichel, Daniel Cohen, Adi Beth-Din, Anat Zvi, Hadar Marcus, Tomer Israely, Nir Paran
Publikováno v:
Vaccines, Vol 10, Iss 2, p 291 (2022)
The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations of specifi
Externí odkaz:
https://doaj.org/article/79c4459068c048c982dd0dd04b24ee33
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0125057 (2015)
BACKGROUND:Megakaryocytes assemble and release platelets through the extension of proplatelet processes, which are cytoplasmic extensions that extrude from the megakaryocyte and form platelets at their tips. Proplatelet formation and platelet release
Externí odkaz:
https://doaj.org/article/4f00c03bdd2b4a7cac25209319a04245
Autor:
Yasmin Maor, Eilat Shinar, Marina Izak, Galia Rahav, Tal Brosh-Nissimov, Asa Kessler, Naomi Rahimi-Levene, Odeda Benin-Goren, Dani Cohen, Iris Zohar, Noga Alagem, Sharon Castro, Oren Zimhony
Publikováno v:
Clinical Infectious Diseases.
Background It is unknown whether convalescent immunoglobulins (cIgG) are better than convalescent plasma (CP) for COVID-19 patients. Methods In this randomized trial we assigned high risk COVID-19 with ≤10 days of symptoms, to receive cIgG or CP. T
Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID ‐19 infection
Autor:
Dorit Blickstein, Marina Izak, Talia Filipovich‐Rimon, Osnat Garach‐Jehoshua, Naomi Rahimi‐Levene, Eilat Shinar, Ramzia Abu Hamad, Adina Bar‐Chaim, Maya Koren‐Michowitz
Publikováno v:
Vox Sanguinis.
Publikováno v:
Vaccine
Currently approved anti-COVID-19 vaccines have been found to be safe and effective and almost 60% of Israeli residents are already vaccinated with BNT162b2 vaccine. This observational study was designed to evaluate the adverse events of vaccine repor
Autor:
Richard Gammon, Pierre Gallian, J. N. S. Leung, David J. Roberts, Karin van den Berg, James Daly, Robby Nur Aditya, Michel Toungouz Nevessignsky, Rekha Hans, Paula Verónica Cini, Pierre Tiberghien, Levent Sagdur, Nil Banu Pelit, Gopal Kumar Patidar, Nancy M. Dunbar, Eilat Shinar, Ivan Hung, Carlos Alberto Gonzalez, Richard Schäfer, Rita A. Reik, Hua Xu, Ru Yang, Khuloud Al Maamari, Salwa Hindawi, Naomi Rahimi-Levene, Patricia Scuracchio, Rahul Chaurasia, Sinyoung Kim, Marion Vermeulen, Hans Vrielink, Lise Sofie H. Nissen-Meyer, Mark H. Yazer, Melissa Lopez, Jarkko Ihalainen, Silvano Wendel, Vincenzo De Angelis, Pampee P. Young, Ratti Ram Sharma, Cynthia So-Osman, Antti Vierikko, Hem Chandra Pandey, Ai Leen Ang, Yan Qiu, Angelo Ostuni, Renée Bazin, Cheuk-Kwong Lee, Giuseppe Marano, Zaid Al-Hinai, Roberta Fachini, Pascal Morel, Marina Izak, Lise J Estcourt, Pierluigi Berti, Tanya Nadia Glatt, David Martin Ferrari, Thierry Burnouf, Veronica C. Hoad, Maha A. Badawi, Levent Tufan Kumaş, Magdy El Ekiaby, Vernon J. Louw, Darrell J. Triulzi, Arwa Z. Al-Riyami, Divjot Singh Lamba, Suchet Sachdev, Kiat Hoe Ong, Dana V. Devine, Sheila Maclennan
Publikováno v:
Vox Sanguinis
Vox Sanguinis, Wiley, 2021, ⟨10.1111/vox.13114⟩
Vox Sanguinis, Wiley, 2021, ⟨10.1111/vox.13114⟩
International audience
Autor:
Oren Zimhony, Sharron Bransburg-Zabary, Eilat Shinar, Marina Izak, Roni Gat, Veronica Gendelman, Boaz Lev, Jacob Chen, Daniel Cohen, Evgeniy Stoyanov, Yasmin Maor, Avi Benov
Publikováno v:
Vox Sanguinis
Background and Objectives Passive immunization using investigational COVID‐19 convalescent plasma (CCP) is a promising therapeutic strategy and could improve outcome if transfused early and contain high levels of anti‐SARS‐CoV‐2 antibodies. W